These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5086355)

  • 1. [Release of an easily soluble drug from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafilov T
    Pharmazie; 1972 Sep; 27(9):586-8. PubMed ID: 5086355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Release of a solid, easily soluble compound from the hydrophobic tablet matrix influenced by surface-active agents].
    Schekerdschijski R; Minkov E; Guschev A; Trandafilov T
    Pharmazie; 1973 Jul; 28(7):450-2. PubMed ID: 4767492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of auxillary substances on the release of hard-to-solve drugs from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafiloff A; Trandafiloff T
    Pharmazie; 1972 Mar; 27(3):167-8. PubMed ID: 4340367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Release insoluble drugs from the hydrophobic tablet matrix. 1].
    Schekerdjiski R; Trandafilov A; Michailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):632-4. PubMed ID: 5149134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Release insoluble drugs from the hydrophobic tablet matrix. 2. Influence of non-ionogenic surface-active substances].
    Schekerdjiski R; Minkov E; Mihailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):635-6. PubMed ID: 5149135
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and diffusion of nitrogen in maltodextrin/protein tablets.
    Schoonman A; Ubbink J; Bisperink C; Le Meste M; Karel M
    Biotechnol Prog; 2002; 18(1):139-54. PubMed ID: 11822912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
    Pajander J; van Veen B; Korhonen O; Lappalainen R; Ketolainen J
    Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
    Tanaka Y; Miyazaki Y; Yakou S; Takayama K
    Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.